Início › Linfoma de Células B › Nova York › New York City
Ensaios clínicos de Linfoma de Células B em New York City, NY
18 estudos para Linfoma de Células B estão buscando participantes em locais em New York City e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
RecrutandoFase 3
- Memorial Sloan Kettering Cancer Center Mskcc, New York
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RecrutandoFase 1
- New York University (NYU) Clinical Cancer Center, New York
- Weill Cornell Medicine, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
RecrutandoFase 2
- Research Site, New York
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
RecrutandoFase 1/2
- Icahn School of Medicine At Mount Sinai, New York
- Columbia University Medical Center, New York
- Weill Cornell Medical College Newyork Presbyterian Hospital, New York
- e mais 1
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
RecrutandoFase 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
RecrutandoFase 1/2
- Research Site, New York
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
RecrutandoFase 1
- Clinical Trial Site, New York
- Clinical Trial Site, New York
A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
RecrutandoFase 1/2
- Research Site, New York
A Study of ARC-02 in B-cell NHL
RecrutandoFase 1
- NYU Langone, New York
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RecrutandoFase 1/2
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies
RecrutandoFase 1/2
- Research Site, New York
DALY II USA/ MB-CART2019.1 for DLBCL
RecrutandoFase 2
- Memorial Sloan Kettering Cancer Center, New York
A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
RecrutandoFase 1/2
- Memorial Sloan Kettering, New York
Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)
RecrutandoFase 2
- Columbia University Irving Medical Center, New York
Study of CAR-T Therapy in Older Patients
RecrutandoEstudo observacional
- Memorial Sloan Kettering Cancer Center, New York
ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL
Recrutando
- Columbia University, New York
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
Recrutando
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
- NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only), New York
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RecrutandoFase 1
- Children's Hospital New York-Presbyterian, New York
- Memorial Sloan Kettering Cancer Center, New York
Ensaios de Linfoma de Células B em outras cidades
- Houston, TX16 estudos
- Chicago, IL13 estudos
- Nashville, TN11 estudos
- Philadelphia, PA11 estudos
- Rochester, MN10 estudos
- Milwaukee, WI9 estudos
- Baldwin Park, CA9 estudos
- Cleveland, OH9 estudos
- Boston, MA8 estudos
- Salt Lake City, UT8 estudos
- Washington, DC7 estudos
- Columbus, OH7 estudos
Outros estudos em New York City
- Câncer de Mama136 estudos
- Câncer de Pulmão de Não Pequenas Células121 estudos
- Câncer (todos os tipos)109 estudos
- Câncer de Próstata103 estudos
- Câncer Metastático93 estudos
- Câncer Colorretal78 estudos
- Câncer de Ovário69 estudos
- Câncer de Pulmão60 estudos
- Mieloma Múltiplo60 estudos
- Câncer de Pâncreas60 estudos
- Câncer Endometrial52 estudos
- Leucemia Mieloide Aguda51 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.